INTRODUCTION
Sirohaem and cobalamin are related macrocyclic structures derived from the ubiquitous tetrapyrrolic primogenitor uroporphyrinogen III (uro'gen III) by a number of enzymic transformations (Scheme 1) [1] [2] [3] [4] . Sirohaem is required as a prosthetic group in the six-electron reduction processes of both sulphite and nitrite reductases [5, 6] . As coenzymes, cobalamins are essential in several aspects of metabolism with enzymes involved in rearrangement and methylation reactions [7] .
Sirohaem and cobalamin are derived from uro'gen III by C-methylation of the tetrapyrrole framework (Scheme 1). Thus two S-adenosyl--methionine (AdoMet)-dependent transmethylations of uro'gen III at positions 2 and 7 produce precorrin-2 (dihydrosirohydrochlorin) [8] . Sirohaem is synthesized via sirohydrochlorin by dehydrogenation of the pyrrocorphin precorrin-2, which is subsequently ferrochelated. However, methylation of precorrin-2 at position 20, as opposed to macrocyclic oxidation, yields precorrin-3 [9] , a transformation that ensures that the substrate is destined for corrin manufacture. Hence precorrin-2 represents the last common intermediate of the sirohaem and cobalamin pathways.
The enzyme that catalyses the transformation of uro'gen III into precorrin-2 is the AdoMet-dependent uro'gen III transmethylase (also referred to as SUMT : AdoMet uroporphyrinogen methyltransferase) [10] [11] [12] . The uro'gen III transmethylases can be categorized as follows : (1) uro'gen III transmethylases with a molecular mass of approx. 30 kDa, which are able only to perform the transmethylation of uro'gen III (e.g. the CobA from Pseudomonas denitrificans [10] ) ; (2) multifunctional enzymes with a molecular mass of approx. 50 kDa
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whereas the mutation of a number of phylogenetically conserved residues within CysG A is detrimental to the transmethylation reaction but does not affect the activity of CysG B . Further studies have shown that CysG B is not essential for cobalamin biosynthesis because the presence of the Salmonella typhimurium CobI operon with either cysG A or the Pseudomonas denitrificans cobA are sufficient for the synthesis of cobyric acid in an E. coli cysG deletion strain. Evidence is also presented to suggest that a gene within the S. typhimurium CobI operon might act as a chelatase that, at low levels of cobalt, is able to aid in the synthesis of sirohaem.
capable of converting uro'gen III into sirohaem (e.g. CysG sirohaem synthase [13] [14] [15] ) ; (3) fusion proteins between CobA (single domain uro'gen III transmethylase) and HemD (uro'gen III synthase), the preceding enzyme in the tetrapyrrole biosynthetic pathway (e.g. in Clostridium josuii [16] ) ; (4) as CobA fusions with proteins of no known function (e.g. in Saccharomyces cere isiae [17] and Bacillus subtilis [18] ). A sequence comparison of some of the type (1) and type (2) enzymes is given in Figure 1 . As a type (2) enzyme, described above, the CysG protein from Escherichia coli has been shown to be a multifunctional enzyme capable of converting uro'gen III into sirohaem [14, 15] and is similar in primary structure and function to the CysG proteins from Salmonella typhimurium [19] and Neisseria meningitidis (M. J. Warren, S. E. Wilkie, T. McVeigh, S. Peters, E. Raux and S. C. Woodcock, unpublished work). CysG is able to catalyse the two AdoMet transmethylations, an NAD + -dependent dehydrogenation as well as ferrochelation. All the isolated cysG genes encode for proteins with molecular masses of approx. 50 kDa, and are associated with operons of sulphite or nitrite metabolism. It is thought that these proteins might have arisen as a result of a gene fusion between a CobA protein (AdoMetdependent transmethylase) and an oxidase\chelatase. With this view in mind the N-terminal domain of CysG is referred to as CysG B (oxidase\dehydrogenase domain) and the C-terminal domain as CysG A (transmethylation domain) [15] .
With respect to the chelation activity of E. coli CysG, it was reported that the enzyme is able to accept a range of divalent metal ions as substrate, including Fe# + , Co# + and Ni# + [14] . It has been suggested that the observed cobalt chelation activity might reflect a function required for corrin biosynthesis [14, 20] and it
Scheme 1 Biosynthesis of sirohaem and cobyric acid from uro'gen III
Uro'gen III is converted into precorrin-2 by two AdoMet-dependent transmethylations at positions 2 and 7 by the action of uro'gen III transmethylases. Oxidation of precorrin-2, such as that afforded by the NAD + -dependent dehydrogenation catalysed by CysG B , yields sirohydrochlorin ; a subsequent ferrochelation gives rise to sirohaem. Methylation of precorrin-2, as opposed to oxidation, produces precorrin-3, which directs the intermediate towards corrin biosynthesis, a process that to make cobyric acid, for instance, requires the action of a further 10 enzymes.
was hypothesized that CysG could insert cobalt into sirohydrochlorin, which is subsequently reduced to give cobaltprecorrin-2. Furthermore, because mutations in S. typhimurium cysG that affect sirohaem synthesis also seem to affect cobalamin biosynthesis in parallel, it has been argued that the two domains of CysG must be essential for both activities [21] . This paper investigates the contribution made by the two functional domains of CysG towards sirohaem and cobalamin biosynthesis and whether the two regions of the protein act independently.
MATERIALS AND METHODS

Chemicals
Most chemicals, reagents and antibiotics were obtained from Sigma Chemical Company (Poole, Dorset, U.K.). Tryptone, yeast extract and agar were purchased from Difco Laboratories (Detroit, MI, U.S.A.). Mimetic Green I affinity chromatography resin was purchased from Affinity Chromatography (Cambridge, U.K.). Restriction endonucleases and PCR requisites were purchased from Promega (Southampton, Hampshire, U.K.). In itro mutagenesis kit, Sequenase kit, [α-$&S]dATP, [methyl-$H]AdoMet (80 Ci\mmol) and Hyperfilm-MP were purchased from Amersham International (Little Chalfont, Bucks., U.K.). Autofluor was purchased from National Diagnostics (Hull, East Yorkshire, U.K.). Oligonucleotide primers were purchased from Genosys (Cambridge, U.K.).
Plasmids and bacteria
All the strains and plasmids used in this study are described in Table 1 . Standard methods for molecular biology were used, as described previously [22] .
For ease of further cloning, the cysG expression strain pSW95 was generated. This was accomplished by amplification of the E. coli cysG (1374 nt) by the PCR method of MacFerrin [23] , with universal primer and a 5h primer containing a GC clamp, a BamHI site, a ribosome-binding site, a transcriptional spacer element and an ATG start codon. The fragment was purified on a 1% (w\v) agarose gel, extracted and digested with the restriction enzymes BamHI\EcoRI and ligated into pUC19, which had been restricted previously in a similar fashion.
A CysG derivative (CysG ∆ NAD ) lacking the N-terminally located NAD + -binding site was expressed from a truncated cysG from which the first 34 codons had been deleted. This was accomplished by amplification of nt 103-1374 from pSW95 by using universal primer and a primer specific for the new 5h end of the truncated gene, which contained the expression features described above. The fragment was amplified by standard PCR methods, purified on a 1 % (w\v) agarose gel, extracted and digested with the restriction enzymes BamHI and EcoRI and then ligated into pUC19 that had been restricted in a similar fashion. This procedure generated pcysG ∆ NAD , which expressed a truncated protein with the N-terminus starting M-GARLTV. The clone was fully sequenced to ensure that no further mutations had been introduced during the PCR procedure.
Point mutants of CysG were generated by using the techniques described in [24] . The mutants were generated in M13mp18 containing the BamHI\EcoRI fragment from pSW95 containing the cysG gene. The cysG mutants G21D, G224A, D227A, D248A, K270I, R298L, D303A and R309L were generated from the following primers : G21D, GTCGGCGCTGATGATGTC ; 
pKK : CobA Pd P. denitrificans cobA sub-cloned from pCR395 This study ; [40] pAR8086 lacI q on pACYC184 [27] G224A, GGTGCAGCTCCGGGCG ; D227A, TCCGGGCGC TGCCGGGCT ; D248A, GGTCTACGCCCGTCTGGT ; K270I, CGTCGGCATACGCGCGGG ; R298L, CGTGGT-GCTGCTGAAAGG ; D303A, GGTGGCGCTCCGTTTA ; R309L, TTTGGCCTTGGTGGCGA. The mutants were verified by DNA sequencing and were cloned subsequently into the BamHI\EcoRI sites of pUC19 to create the following plasmids :
Transformation of these plasmids into TB1 afforded expression of the mutant protein.
Subcloning of cysG, cysG A and the cysG point mutants were undertaken with standard techniques [22] to generate the list of plasmids described in Table 1 . A brief outline of the cloning procedure is also contained within Table 1 .
Complementation experiments
The E. coli cysteine auxotroph 302∆a was transformed with plasmids containing cysG or the cysG mutants ; these were then grown on minimal medium in the presence or absence of cysteine. The ability of the recombinant strains to synthesize sirohaem was measured by their capacity to grow in the absence of exogenous cysteine.
Enzyme purification
The proteins CysG, CysG G#"D , CysG K#(!I , CysG D$!$A , CysG R$!*L and CysG A were purified by previously published methods [15] . The remaining enzymes, CysG ∆ NAD , CysG G##%A , CysG D#%)A and CysG R#*)L were overexpressed largely in the form of inclusion bodies and therefore initially had to be resolubilized before isolation. This was accomplished as follows : a 3 litre culture of the relevant strain was grown overnight and harvested by centrifugation. The cell pellet (10 g) was resuspended in 50 ml of 50 mM Tris\HCl, pH 7.8, and the resulting suspension was sonicated for four 1 min bursts with 1 min of cooling between each burst in an MSE ultrasonicator (8-10 µm). The solution was centrifuged at 12 000 g for 10 min and the pellet was resuspended in ' inclusion body wash buffer ' [50 mM Tris\HCl (pH 7.8)\100 mM NaCl\15 mM EDTA\0.5 % (v\v) Triton X-100] and then centrifuged at 12 000 g for 10 min. The supernatant was discarded and the pellet was resuspended in 6 M urea in 20 mM Tris\HCl, pH 7.8, and incubated at room temperature for 30 min. This was centrifuged at 12 000 g for 10 min, by which stage most of the protein was found in solution. This solution was dialysed overnight against 5 litres of 50 mM Tris\HCl, pH 7.8, containing 13 mM 2-mercaptoethanol. Throughout the purification the protein was detected by SDS\PAGE and was assayed with a rapid AdoMet binding assay [25, 26] . The alignment was generated using the PILEUP program from the UWGCG package [41] . (a) Alignment of the predicted amino acid sequences of the uro'gen III transmethylase sequences (CysG A ) from Anacystis nidulans [42] , Synechocystis sp. (accession number ss110378), Arabidopsis thaliana [35] , Zea mays [43] , Paracocccus denitrificans [44] , Methanobacterium ivanovii [45] , Methanococcus jannaschii [46] , Bacillus subtilis [18] , Bacillus megaterium [12] , Bacillus stearothermophilus [47] , Escherichia coli [13] , Propioni freudenreichii [48] and Pseudomonas denitrificans [10] . The consensus sequence is shown and the mutated residues are marked by an asterisk. (b) Alignment of the predicted amino acid sequences of the dehydrogenase/ferrochelatase domains (CysG B ) from Escherichia coli [13] , Salmonella typhimurium [19] , Vibrio anguillarium [49] and Clostridium josuii [16] . The consensus sequence is shown and the predicted NAD + -binding site is underlined. The mutated residue Gly-21 is marked by an asterisk.
The AdoMet binding assays were performed as described previously [25, 26] by analysis of the profile of a [methyl-$H]-AdoMet\protein mixture after chromatography on a Sephadex G-25 column (1 cmi20 cm). Briefly, protein (1 mg) was preincubated with 0.5 µCi of [methyl-$H]AdoMet (specific radioactivity 80 Ci\mmol) in a final volume of 200 µl. The mixture was applied to the Sephadex G-25 column ; 1 ml fractions were collected. AdoMet binding was identified by the presence of a significant quantity of radioactivity in the protein-containing fractions. Fluorograms were taken of SDS\PAGE gels containing 10-20 µg of protein that had been premixed with the labelled AdoMet as described previously [26] .
Quantification of cobyric acid synthesis by bioassay
Cobyric acid levels were determined by the modification of the agar plate bioassay system as described by Raux et al. [27] . The indicator strain used for this assay was AR3612, S. typhimurium cysG metE. Exogenously added cobyric acid promoted growth of the strain on minimal medium plates supplemented with cysteine. The growth dependence of the strain allowed a standard curve to be constructed.
Preparation of bacteria for estimation of cobyric acid synthesis
The levels of cobyric acid in the strains of interest were estimated in extracts of the bacteria after they had been prepared as follows : bacteria were grown under anaerobic conditions in minimal medium [27] supplemented with antibiotics. After harvesting of the cells by centrifugation, the cells were resuspended in water to a D '!! of 8, then sonicated. A 10 µl droplet of the extract was then bioassayed.
RESULTS
Construction of CysG AdoMet-binding site variants and conserved amino acids found within CysG
A
The AdoMet-binding site of the transmethylase domain (CysG A ) was subjected to mutagenesis by changing residues 224 (Gly) and 227 (Asp) to Ala, which are found in the putative AdoMetbinding motif GXGXGD of the uro'gen III methyltransferases ( Figure 1a) [25, 28, 29] . The mutations were performed with the techniques described in the Materials and methods section and were verified by sequencing. The mutated genes were cloned into both pUC19 and pKK223-3 vectors ( Table 1 ). The mutant proteins expressed from these plasmids were analysed initially for their ability to complement the E. coli cysG deletion mutant 302∆a [15, 30] and to bind AdoMet [25, 26] .
Other conserved charged amino acids in the CysG A domain include D248, K270, R298, D303 and R309, which are located in regions of the primary structure that are thought to be involved in binding and catalysis [25, 29, 31] (Figure 1a) . The residues were mutated with the techniques described in the Materials and methods section and were verified and analysed as described above.
Construction of NAD + -binding site variants within CysG B
The contribution of the CysG B domain to sirohaem synthase activity was investigated by altering the NAD + -binding site. Initially this was performed by making a truncated version of cysG, lacking the first 34 codons from the 5h end of the gene. The truncated gene, cysG ∆ NAD , was cloned into both pUC19 and
Figure 2 Rapid AdoMet binding assay of CysG and a number of mutant variants
The purified protein was incubated with 0.5 µCi of [methyl-3 H]AdoMet and passed down a small gel-filtration column. The protein was eluted in fractions 4-6, whereas the smaller molecules were eluted in fractions 9-14. If the protein was co-eluted with some of the radioactivity it was deemed to be capable of binding AdoMet. pKK223-3 to yield pcysG ∆ NAD and pKKcysG ∆ NAD respectively. When these plasmids were transformed into E. coli TB1 the recombinant strains were found to express a shortened protein (45 kDa as opposed to 50 kDa [11] ), which was clearly seen when crude cell extracts were analysed by SDS\PAGE (results not shown). Furthermore the cells that expressed CysG ∆ NAD were very fluorescent when viewed under UV light, a phenotypic characteristic shared with cells overexpressing CysG A [15] . The fluorescence is due to the accumulation of sirohydrochlorin and trimethylpyrrocorphin within the cell [15, 32] .
As well as the NAD + -binding site-deficient protein, CysG ∆ NAD , another NAD + -binding site variant was generated through the introduction of a point mutation at Gly-21 (Gly-21 Asp). Glycine-21 makes up part of the GXGXXG nucleotide-binding site of CysG [29, 33] (Figure 1b) and the inclusion of a charged polar amino acid in a key part of the putative Rossman fold [34] was envisaged to disrupt the structure and prevent the binding of NAD + . When E. coli TB1 was transformed with pcysG G#"D , the cells also exhibited a strong fluorescence under UV light. Thus all CysG derivatives with a missing or altered NAD + -binding site 
AdoMet-binding studies on CysG variants
To assess whether the CysG variants described above were able to form a tightly bound complex with AdoMet as described previously [26] , the purified proteins were analysed for their ability to bind AdoMet during gel filtration. In this case the assay was used as a simple qualitative test to determine the presence of an AdoMet-binding protein. The result of the binding assay with CysG A is shown in Figure 2a . The rapid binding assay demonstrated that a large amount of the label was co-eluted with the CysG A fraction, whereas in control experiments with BSA the label was eluted exclusively in the small molecules fractions. Further experiments clearly demonstrated that along with CysG A , CysG G#"D , CysG ∆ NAD , CysG D#%)A , CysG K#(!I , CysG D$!$A and CysG R$!*L were also able to bind AdoMet (Figures 2a and  2b) . In contrast, CysG G##%A and CysG R#*)L were unable to bind AdoMet, implying that these proteins might not be able to perform the transmethylation reaction (Figures 2a and 2b) . The AdoMet-binding capacity of the modified versions of CysG was confirmed by fluorography. This was achieved by incubation of the enzyme with [methyl-$H]AdoMet, as described in the the Materials and methods section, and subsequently subjecting the protein sample to SDS\PAGE. After the gel had been dried and placed next to X-ray film, the fluorogram was developed to reveal that CysG A , CysG G#"D , CysG ∆ NAD , CysG D$!$A and CysG R$!*L were all radioactive (results not shown).
Functional complementation of the E. coli cysG deletion strain 302∆a
In earlier studies it had been shown that the E. coli cysteine auxotrophic strain 302∆a was deficient in all sirohaem synthase activity and could not be complemented by CysG A [15] . Similarly when the strain was transformed with a plasmid carrying the cobA gene of P. denitrificans (pER119) ( Table 2) complementation was not observed. We also investigated the effect of the mutant cysG variants as well as other modified cysG constructs on their ability to complement the cysteine auxotrophy of the E. coli cysG deletion strain 302∆a ; the results of these tests are shown in Table 2 . Point mutations in CysG at positions 227 (D A), 270 (K I) and 303 (D A) did not prevent complementation when plasmids harbouring these mutant CysG derivatives were transformed into the E. coli cysG deletion strain 302∆a. However, point mutations in CysG at positions 224 (G A), 248 (D A), 298 (R L) and 309 (R L) gave proteins that were unable to complement the auxotrophic mutant ( Table  2) .
The effect of the mutation at position 21 (G D) and the removal of the NAD + -binding site in the CysG B domain were also assessed for their effect on sirohaem synthesis. Complementation of 302∆a by the plasmid pCysG G#"D was observed even though this plasmid overexpresses a protein with greatly decreased dehydrogenase activity (less than 1 % of wild-type CysG ; results not shown). However, complementation of the E. coli cysG deletion strain 302∆a was not observed by the plasmid carrying the NAD + -deleted protein, pcysG ∆ NAD (Table 2 ). To investigate whether the CysG A and CysG B regions could function independently, dual plasmid complementation studies were undertaken. The E. coli cysG deletion strain 302∆a was transformed with one of the mutant cysG derivatives (pcysG G##%A , pcysG D#%)A , pcysG R#*)L or pcysG R$!*L ) harboured on pUC19, together with pSW100, which contains the truncated gene for the functional transmethylase domain of CysG, cysG A , on a pACYC184-derived plasmid. In each case, complementation of the auxotrophic strain was attained (Table 2) . Identical results were obtained when the experiment was repeated with the mutated cysG genes cloned on the same plasmid with cysG A . Thus plasmids pSW101, pSW102, pSW103 and pSW104 all complemented the E. coli cysG deletion strain 302∆a (Table 2) .
Cobalamin biosynthesis
To find a definitive answer to the question of whether all or part of CysG is required for cobalamin biosynthesis, the E. coli cysG deletion mutant 302∆a was transformed with pAR8827, a plasmid that contains all the S. typhimurium genes required for the transformation of precorrin-2 into cobyric acid, and was designated AR8906. Levels of cobyric acid, a late corrin intermediate, can be accurately determined by using a very sensitive bioassay system [27] ; this method was used to determine the levels of cobyric acid synthesized in this study. When grown anaerobically in minimal medium in the presence of added cobalt, 5-aminolaevulinic acid, cysteine and isopropyl β--thiogalactoside, AR8906 was unable to synthesize any cobyric acid (Table 3) . However, when AR8906 (302∆a\pAR8827 ; cysG deletion, CobI + ) was further transformed with pAR8414, a plasmid that harbours the E. coli cysG, cobyric acid was produced to levels of 580 pmol of cobyric acid per attenuance unit of bacteria (Table 3) . These results indicate that the E. coli cysG is required for corrin biosynthesis and that its absence, as expected, prevents corrin production because the bacterium is unable to transform uro'gen III into precorrin-2.
Strain AR8906 (302∆a\pAR8827) was further transformed with plasmids containing cysG
The resulting strains were examined for their ability to grow on minimal medium and to produce cobyric acid (Table 3) . When AR8906 was transformed with a plasmid containing cysG A it produced approx. 12 pmol of cobyric acid per attenuance unit (Table 3) . When the P. denitrificans cobA gene (pER119) was transformed into AR8906 (E. coli cysG deletion, CobI + ) cobyric acid was produced to a level of 500 pmol per attenuance unit ( Table 3) . Transformation of AR8906 with pcysG G#"D gave a strain which produced cobyric acid at a level of 190 pmol per attenuance unit (Table 3) .
Rather surprisingly, AR8906 (E. coli cysG deletion, CobI + ) transformed with pcysG A was found to be able to grow on minimal medium in the absence of cysteine, albeit quite slowly (Table 2 ). When exogenous cobalt was added to the minimal medium plates, complementation was prevented.
DISCUSSION
Rationale for the construction of CysG variants
Previously it had been shown that it is possible to express the CysG A domain of sirohaem synthase as a truncated protein by dissecting cysG into separate cysG A and cysG B entities [15] . However, attempts to express the N-terminal domain, CysG B , proved to be unsuccessful. To assess the roles of the two functional domains CysG A and CysG B , a number of mutations and a truncation of CysG were made. Variations to CysG were made in the putative AdoMet-binding site of CysG A (G224A and D227A) (Figure 1a) , a number of highly conserved residues in CysG A (D248A, K270L, D303A, R298L and R309L) (Figure 1a ) and the NAD + -binding site of CysG B (G21D, and a NAD + -binding site-deleted enzyme, CysG ∆ NAD ) (Figure 1b) . The replacement residues were selected for their lack of functionality, with consideration given to spatial and chemical properties, and also to the ease with which it was possible to change the codon.
Effect of mutation on AdoMet binding
The transmethylation reaction catalysed by CysG seems to proceed via an enzyme-AdoMet covalent complex [26] , although the precise nature of the interaction between the enzyme and substrate has not been determined. All the mutant proteins were tested for their ability to bind AdoMet. Alterations to the CysG B domain had no effect on AdoMet binding : CysG A , CysG G#"D and CysG ∆ NAD all associated with AdoMet on gel filtration. However, as expected, mutations within the transmethylase functional domain (CysG A ) had a more pronounced effect on AdoMet binding. The mutant CysG G##%A was unable to bind AdoMet significantly. Glycine-224 makes up part of the glycine-rich motif, which is thought to constitute a Rossman-type fold associated with binding both AdoMet and dinucleotide cofactors. The mutation of Arg-298 to Leu also prevented AdoMet binding and thus Arg-298 must presumably have a role in AdoMet recognition. The mutants, CysG D#%)A and CysG R$!*L , did not seem to affect AdoMet binding. However, from the results presented in Figure 2 (b) it is apparent that CysG K#(!I and CysG D$!$A bind less AdoMet than do CysG and some of the other variants. It is not possible from this result to determine whether this is due to a lower affinity for the substrate, whether the mutant enzyme has more bound unlabelled AdoMet, or whether, proportionally, the enzyme preparations from which these mutant proteins were obtained contain less active enzyme. This is due to the lack of a suitable active-site titrant for CysG.
Effect of mutations on complementation of the E. coli cysG deletion strain 302∆a
The E. coli cysG deletion strain 302∆a is deficient in all CysG functions, that is the strain has no measurable transmethylase, dehydrogenase or ferrochelatase activity. In general, for the transmethylase mutants, the complementation of this cysteine auxotrophic strain followed the results observed in the AdoMet binding assay. Thus the mutants that did not bind AdoMet, CysG G##%A and CysG R#*)L , did not complement. Of particular interest from this study are mutants CysG R$!*L and CysG D#%)A , which are able to bind AdoMet but do not complement the E. coli cysG deletion strain. These mutations must be specific for the transmethylation reaction because they did not affect the ferrochelation or dehydrogenation ability of the protein, a conclusion that is deduced from the dual-plasmid complementation experiments with cysG A . Presumably the mutations at positions 248 and 309 either prevent the binding of the other substrate, uro'gen III, or inhibit the transmethylation reaction.
All the other transmethylase domain mutants (D227A, K270I and D303A) were able to complement the cysteine auxotrophic strain. This indicates that these residues are not essential in the catalytic process and that the change did not lead to a detrimental loss of structure.
The effects of the mutations and alterations within CysG B on the ability to complement the E. coli cysG deletion strain were varied. As reported before, complete loss of the CysG B domain does not allow complementation [15] . However, a point mutation within the dinucleotide-binding fold, G21D, does allow complementation even though the mutant protein has a barely measurable dehydrogenase activity. As CysG G#"D is able to make precorrin-2, the complementation can be explained on the basis that a certain amount of spontaneous oxidation of precorrin-2 occurs within the cell, producing sirohydrochlorin [15] . This in turn is ferrochelated by the CysG G#"D variant by the insertion of a ferrous ion into the chemically oxidized precorrin-2.
The modified enzyme lacking the NAD + -binding site, CysG ∆ NAD , was unable to complement the E. coli cysG deletion strain. This suggests that some of the first 34 amino acid residues are probably important for the correct folding of the ferrochelation active site and that the deletion of the N-terminal arm prevents the proper folding of the CysG B domain. Alternatively, the N-terminal arm, which probably adopts a β-α-β nucleotidebinding fold, might also harness some critical chelatase functional residues.
CysG functional domains (CysG A and CysG
B ) seem to operate independently
As alluded to earlier, complementation of the E. coli cysG strain can be attained by expression of a transmethylase-functional protein (either CysG A or CobA) and a transmethylase-deficient CysG (e.g. CysG G##%A , CysG D#%)A , CysG R#*)L or CysG R$!*L ). Such results suggest that the intermediate precorrin-2 is diffusible between CysG A and the transmethylase-deficient CysG mutants. Thus CysG A synthesizes precorrin-2, which is transformed into sirohaem by the CysG B functional domain of the mutant CysG. This is an important point as it could be argued that the reason for the CysG BA architecture is to facilitate substrate channelling and that direct metabolite transfer within the multifunctional enzyme might have evolved because of the chemical lability of precorrin-2. The results described here show that the biosynthesis of sirohaem can be accomplished with a two-enzyme system. Two-enzyme systems for sirohaem biosynthesis have been inferred from previous work on Bacillus megaterium [12] and in the higher plant Arabidopsis thaliana [35] . Recently sirohaem synthesis from uro'gen III in S. cere isiae has been shown to require two proteins, Met1 and Met8 [17] , although the functions of the two proteins have not been accurately ascribed.
CysG and cobalamin biosynthesis
Although E. coli does not possess the genes that encode for the enzymes required to convert precorrin-2 into cobinamide (CobI genes), it is able to convert cobinamide into both adenosylcobalamin and methylcobalamin, i.e. it contains the CobII and CobIII genes [36] . However, the closely related enteric species Salmonella typhimurium possesses all the genes for cobalamin biosynthesis de no o, although cobalamin synthesis is attained only under anaerobic conditions [37] . It has previously been shown that the S. typhimurium cysG, which is more than 90 % identical with the E. coli cysG, is required for cobalamin biosynthesis [37] . Nevertheless, it is not known whether the whole CysG protein, both the CysG B and the CysG A domains, is necessary for cobalamin biosynthesis or whether merely the CysG A (transmethylase) domain is required.
Only the transmethylase function of CysG (CysG
A ) is required for promotion of cobalamin biosynthesis
When the E. coli cysG deletion strain 302∆a is transformed with a plasmid carrying the S. typhimurium CobI operon (pAR8827), producing AR8906, the strain is unable to synthesize cobyric acid because it does not contain a functional cysG. When AR8906 (E. coli cysG, CobI + ) is transformed with a compatible plasmid harbouring cysG A , cobyric acid is synthesized, albeit at 2 % of the level observed when the strain is transformed with a plasmid carrying the complete cysG. The fact that CysG A is able to make any corrin suggests that CysG B is not essential for cobalamin biosynthesis and it seems that the biosynthesis of precorrin-2 is a prerequisite for cobalamin synthesis. However, corrin production in AR8906 transformed with a plasmid carrying cysG A is only 2 % of that measured in AR8906 transformed with cysG (Table 3) . There are two possible explanations for this low level of synthesis. First, CysG A is known to produce a large quantity of the overmethylated compound, a 2,7,12-trimethylpyrrocorphin, which has no known physiological function [8] . By making such large quantities of this compound the enzyme is lowering the precorrin-2 concentration, effectively removing the substrate from the cobalamin biosynthetic pathway. Secondly, if CysG B is required for the facilitation of cobalt chelation of precorrin-2, then in its absence the ' chemical ' or non-enzymic chelation of precorrin-2 would be expected to be dependent on the presence of endogenous cobalt in the strain AR8906\pcysG A . No such dependence was observed (results not shown).
The former possibility described above, that the reduced level of cobyric acid is due to the overmethylating activity of CysG A , was investigated by looking at the effect of a uro'gen III transmethylase that does not overmethylate to the same extent as CysG A . Such a uro'gen III transmethylase is CobA from P. denitrificans [10] . Transformation of AR8906 (E. coli cysG, CobI + ) with a plasmid harbouring cobA results in the production of cobyric acid at levels observed with cysG. This would suggest that it is the overmethylating activity of CysG A that is responsible for the lower levels of cobyric acid rather than the lack of a CysG B domain.
However, CysG B might have some role in regulating the activity of CysG A because transformation of AR8906 with a plasmid containing both CysG A and CysG R$!*L (pKKSW104) produced a strain that made cobyric acid at 506 pmol per attenuance unit (Table 3) . Thus, under physiological conditions, CysG B might regulate and stabilize precorrin-2 synthesis and prevent the excessive accumulation of the overmethylated trimethylpyrrocorphin.
S. typhimurium CobI gene with an equivalent function to CysG B
Unexpectedly, the cysteine auxotrophy of E. coli 302∆a was complemented by the presence of the S. typhimurium CobI operon and cysG A . This would suggest that sirohaem can be made by a mechanism that does not require CysG B . Similarly, complementation of the cysteine auxotrophy was observed when the P. denitrificans cobA gene was used to transform AR8906. A possibility is that an enzyme involved in cobalamin biosynthesis within the CobI operon is able to chelate iron instead of cobalt at the level of precorrin-2 on the minimal medium plates. To test this theory, the minimal medium plates on which the strain was able to grow were supplemented with exogenous cobalt. The presence of the exogenous cobalt prevented growth on minimal medium of AR8906\pcysG A but did not affect growth of AR8906\pAR8414 (CysG). Thus the observed growth on minimal medium in the absence of cobalt might be due to iron acting as a surrogate metal at the level of precorrin-2. Evidence has previously been provided that strongly suggests that during corrin biosynthesis cobalt is added at the level of precorrin-2 [27] . Spontaneous oxidation of this compound would then yield sirohaem. Recently the cbi gene responsible for the CysG B -like activity within the S. typhimurium CobI operon has been shown to be cbiK [38] .
In summary, a number of cysG variants have been constructed with changes in either the transmethylase or oxidase\chelatase regions of the protein. These have been investigated for their ability to bind AdoMet, complement an E. coli cysG deletion strain, and contribute to cobalamin biosynthesis. The results provide evidence that the two domains of cysG can act independently. In terms of cobalamin biosynthesis, only the CysG A (transmethylase) domain of CysG is required because corrin biosynthesis is promoted in the absence of CysG B . However, evidence is presented that a gene within the S. typhimurium CobI operon encodes a protein with CysG B functionality.
